|
|
|
|
LEADER |
01432 am a22002653u 4500 |
001 |
81974 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Salvi, Luca
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Chemistry
|e contributor
|
100 |
1 |
0 |
|a Salvi, Luca
|e contributor
|
100 |
1 |
0 |
|a Davis, Nicole Rose
|e contributor
|
100 |
1 |
0 |
|a Ali, Siraj Z.
|e contributor
|
100 |
1 |
0 |
|a Buchwald, Stephen Leffler
|e contributor
|
700 |
1 |
0 |
|a Ali, Siraj Z.
|e author
|
700 |
1 |
0 |
|a Davis, Nicole Rose
|e author
|
700 |
1 |
0 |
|a Buchwald, Stephen Leffler
|e author
|
245 |
0 |
0 |
|a A New Biarylphosphine Ligand for the Pd-Catalyzed Synthesis of Diaryl Ethers under Mild Conditions
|
260 |
|
|
|b American Chemical Society (ACS),
|c 2013-11-04T17:05:49Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/81974
|
520 |
|
|
|a A new bulky biarylphosphine ligand (L8) has been developed that allows the Pd-catalyzed C-O cross-coupling of a wide range of aryl halides and phenols under milder conditions than previously possible. A direct correlation between the size of the ligand substituents in the 2', 4', and 6' positions of the nonphosphine containing ring and the reactivity of the derived catalyst system was observed. Specifically, the rate of coupling increased with the size of these substituents.
|
520 |
|
|
|a National Institutes of Health (U.S.) (Grant GM58160)
|
520 |
|
|
|a Amgen Inc.
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Organic Letters
|